Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.

P. Sonneveld; B. van der Holt; C.M. Segeren; E. Vellenga; A.J. Croockewit; G.E.G. Verhoef; J.J. Cornelissen; M.R. Schaafsma; M.H.J. van Oers; P.W. Wijermans; P.H.M Westveer; H.M. Lokhorst

Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.

Translated title of the contribution: Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.

P. Sonneveld, B. van der Holt, C.M. Segeren, E. Vellenga, A.J. Croockewit, G.E.G. Verhoef, J.J. Cornelissen, M.R. Schaafsma, M.H.J. van Oers, P.W. Wijermans, P.H.M Westveer, H.M. Lokhorst

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.
Original language	Undefined/Unknown
Pages (from-to)	928-935
Number of pages	8
Journal	Haematologica
Volume	92
Issue number	7
Publication status	Published - 2007

Cite this

Sonneveld, P., van der Holt, B., Segeren, C. M., Vellenga, E., Croockewit, A. J., Verhoef, G. E. G., Cornelissen, J. J., Schaafsma, M. R., van Oers, M. H. J., Wijermans, P. W., Westveer, P. H. M., & Lokhorst, H. M. (2007). Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial. Haematologica, 92(7), 928-935.

@article{e4b8353dddd6439ca5fd59f318b01712,

title = "Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.",

author = "P. Sonneveld and {van der Holt}, B. and C.M. Segeren and E. Vellenga and A.J. Croockewit and G.E.G. Verhoef and J.J. Cornelissen and M.R. Schaafsma and {van Oers}, M.H.J. and P.W. Wijermans and P.H.M Westveer and H.M. Lokhorst",

year = "2007",

language = "Undefined/Unknown",

volume = "92",

pages = "928--935",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "7",

}

Sonneveld, P, van der Holt, B, Segeren, CM, Vellenga, E, Croockewit, AJ, Verhoef, GEG, Cornelissen, JJ, Schaafsma, MR, van Oers, MHJ, Wijermans, PW, Westveer, PHM & Lokhorst, HM 2007, 'Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.', Haematologica, vol. 92, no. 7, pp. 928-935.

TY - JOUR

T1 - Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.

AU - Sonneveld, P.

AU - van der Holt, B.

AU - Segeren, C.M.

AU - Vellenga, E.

AU - Croockewit, A.J.

AU - Verhoef, G.E.G.

AU - Cornelissen, J.J.

AU - Schaafsma, M.R.

AU - van Oers, M.H.J.

AU - Wijermans, P.W.

AU - Westveer, P.H.M

AU - Lokhorst, H.M.

PY - 2007

Y1 - 2007

M3 - Article

SN - 0390-6078

VL - 92

SP - 928

EP - 935

JO - Haematologica

JF - Haematologica

IS - 7

ER -